Acumen Pharmaceuticals, Inc. (ABOS) Revenue History
Acumen Pharmaceuticals, Inc. (ABOS) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $66.00K |
| 2022-12-31 | $43.00K |
| 2023-12-31 | $5.00K |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How ABOS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| BNTC | Benitec Biopharma Inc. | $75.00K |
| INO | Inovio Pharmaceuticals Inc. | $65.34K |
| INMB | INmune Bio Inc. | $50.00K |
| ALT | Altimmune Inc. | $41.00K |
| ALLO | Allogene Therapeutics Inc. | $22.00K |
These are five companies in the same sector as ABOS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Acumen Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("ABOS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ABOS | $2.47 | +1.65% | 0.20M |
| 3 | ||||
| 4 | ||||
| 5 |